Press & Media

SkinMedica® Launches Lytera™ Skin Brightening Complex

SkinMedica® Launches Lytera™ Skin Brightening Complex
A skin brightening product that addresses the appearance of skin discoloration.

Carlsbad, CA – SkinMedica®, the fastest growing professional skin care brand for the past six years, introduces a revolution in skin brightening.  SkinMedica® Lytera™ Skin Brightening Complex is a hydroquinone-free skin brightening product that reduces the appearance of skin discoloration and dark spots.  In clinical studies, Lytera demonstrated similar efficacy when compared to 4% hydroquinone. 

Featuring a proprietary blend of ingredients, SkinMedica® Lytera™ Skin Brightening Complex works to brighten and even skin tone by reducing the appearance of dark spots and skin discoloration.  This luxurious formula contains highly effective antioxidants which help to reveal a smooth, luminous complexion—a naturally beautiful you. 

“Recent advances have given numerous options for those seeking anti-aging therapies however, treatment of dark patches and hyperpigmentation is just as important in rejuvenation as fine lines and wrinkles, and there is a lack of truly efficacious treatments available in this arena,” says board-certified dermatologist, Dr. Annie Chiu.  “The strong clinical results and multi-modal formulation of Lytera™ Skin Brightening Complex makes it a unique and vital addition to any brightening regimen” added Dr. Chiu.

In a recently published clinical study:

  • 85% of patients saw a greater improvement in overall skin condition after 12 weeks of treatment, as compared to 68% of patients treated with 4% hydroquinone.
  • 79% of patients reported greater improvement in evenness of skin tone after 12 weeks of treatment, as compared to 65% treated with 4% hydroquinone.

SkinMedica® Lytera™ Skin Brightening Complex ($125) and the SkinMedica® Skin Brightening System ($250) featuring Lytera™ Skin Brightening Complex, Facial Cleanser, Tri-Retinol Complex ES™ and Daily Physical Defense™ SPF 30+ Sunscreen will be available beginning February 2013 exclusively through licensed physicians and medically supervised spas. Visit for locations.

For more information on SkinMedica® or for product requests, please contact Stephanie Boccuzza or Chrissy Baum at ShopPR, 212.829.1111.

Reference:  Makino ET, et al.  J Drugs Dermatol. 2012;11(12):1478-1482.


About SkinMedica

SkinMedica, Inc. is focused on developing, acquiring, and commercializing products that improve the appearance of skin. SkinMedica markets and sells to physicians, with a focus on aesthetics, both prescription and non-prescription skin care products. The company's full line of aesthetic skin care products includes the revolutionary TNS Essential Serum® and hallmark TNS Recovery Complex®. The formulations in SkinMedica’s clinical skin care collection enhance skin appearance, reduce signs of aging, and provide other skin care benefits. SkinMedica's primary prescription product, VANIQA® (eflornithine hydrochloride) Cream 13.9%, is the only FDA-approved prescription product for the reduction of unwanted facial hair in women. Colorescience Pro’s dermatologist recommended, high-performance cosmetics are formulated to remedy and camouflage specific skin concerns and protect skin from damaging effects of the sun and environment. Colorescience Pro’s luxury aesthetic makeup line is sold in the physician and medical spa channels.

TNS Recovery Complex®, VANIQA®, and SkinMedica®, are registered trademarks of SkinMedica, Inc and affiliates.